Novel, acidic CCR2 receptor antagonists: From hit to lead

被引：15
|
作者：
Zou, D.
Zhai, H. A.
Eckman, J.
Higgins, P.
Gillard, M.
Knerr, L.
Carre, S.
Pasau, P.
Collart, P.
Grassi, J.
Libertine, L.
Nicolas, J. -M.
Schwartz, C. E.
机构：
[1] UCB Res Inc, Cambridge, MA 02139 USA
[2] UCB Pharma, B-1420 Braine lAlleud, Belgium
来源：
LETTERS IN DRUG DESIGN & DISCOVERY | 2007年 / 4卷 / 03期
关键词：
MCP-1; CCR2; chemokine receptor; antagonist; inflammation; hit to lead;
D O I：
10.2174/157018007780077381
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
High throughput screening identified a pyrrolidinone containing acidic functionality as a CCR2 antagonist of modest affinity. We describe initial SAR around this hit, including solution phase parallel synthesis for analog preparation, and we describe identification and characterization of an analog subsequently selected as a viable lead molecule for further optimization.
引用
收藏
页码：185 / 191
页数：7
相关论文
共 50 条
  • [41] Homology modeling of human CCR2 receptor
    Rajesh Singh
    M. Elizabeth Sobhia
    Medicinal Chemistry Research, 2011, 20 : 1704 - 1712
  • [42] Homology modeling of human CCR2 receptor
    Singh, Rajesh
    Sobhia, M. Elizabeth
    MEDICINAL CHEMISTRY RESEARCH, 2011, 20 (09) : 1704 - 1712
  • [43] CCR2 chemokine receptor and AIDS progression
    Michael W. Smith
    Mary Carrington
    Cheryl Winkler
    Deborah Lomb
    Michael Dean
    Gavin Huttley
    Stephen O'brien
    Nature Medicine, 1997, 3 : 1052 - 1053
  • [44] Fingerprint directed scaffold hopping for identification of CCR2 antagonists
    Nair, Pramod C.
    Sobhia, M. Elizabeth
    JOURNAL OF CHEMICAL INFORMATION AND MODELING, 2008, 48 (09) : 1891 - 1902
  • [45] Evaluation of a novel chemokine receptor 2 (CCR2)-antagonist in painful diabetic polyneuropathy
    Kalliomaki, Jarkko
    Jonzon, Bror
    Huizar, Karin
    O'Malley, Michael
    Andersson, Anita
    Simpson, David M.
    SCANDINAVIAN JOURNAL OF PAIN, 2013, 4 (02) : 77 - 83
  • [46] Discovery of trisubstituted cyclohexanes as a new class of CCR2 antagonists
    Cherney, Robert J.
    Mo, Ruowei
    Meyer, Dayton T.
    Nelson, David J.
    Lo, Yvonne C.
    Yang, Gengjie
    Scherle, Peggy A.
    Mandlekar, Sandhya
    Wasserman, Zelda R.
    Jezak, Heather
    Solomon, Kimberly A.
    Tebben, Andrew J.
    Carter, Percy H.
    Decicco, Carl P.
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2007, 233 : 641 - 641
  • [47] Discovery of ONO-7300243 from a Novel Class of Lysophosphatidic Acid Receptor 1 Antagonists: From Hit to Lead
    Terakado, Masahiko
    Suzuki, Hidehiro
    Hashimura, Kazuya
    Tanaka, Motoyuki
    Ueda, Hideyuki
    Kohno, Hiroshi
    Fujimoto, Taku
    Saga, Hiroshi
    Nakade, Shinji
    Habashita, Hiromu
    Takaoka, Yoshikazu
    Seko, Takuya
    ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (10): : 913 - 918
  • [48] 2-mercaptoimidazoles, a new class of potent CCR2 antagonists
    Van Lommen, G
    Doyon, J
    Coesemans, E
    Boeckx, S
    Cools, M
    Buntinx, M
    Hermans, B
    VanWauwe, J
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2005, 15 (03) : 497 - 500
  • [49] Discovery of a novel CCR2 antagonist as development candidate via divergent SARs of CCR2 and hERG
    Zhang, Xuqing
    Hou, Cuifen
    Hufnagel, Heather
    Markotan, Thomas
    Lanter, James
    Cai, Chaozhong
    Singer, Monica
    Opas, Evan
    McKenney, Sandra
    Crysler, Carl
    Johnson, Dana
    Sui, Zhihua
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2012, 244
  • [50] MEDI 255-First time disclosure of a novel series of CCR1 antagonists: From library hit to optimized lead
    Merritt, J. Robert
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2008, 236
12345